19. Please provide a copy of the board minutes and papers in respect of approving the loan to iGalen (not for release to the market). We are unable to locate the Board minutes kept by previous company secretary.
Cant find the minutes to the approval of the loan to "my other company"
20. Where is the iGalen loan recorded in HCT’s 31 December 2019 annual report? See Notes to Account 5.2.4 (page 49 Annual Report 2019)
Recorded in the annual report but cannot find the minutes......HHHMMMM
21. Please advise which HCT directors were responsible for making the decision to impair the loan owing from iGalen? This decision was made by Daniel O’Connor and Jonathan Pager. Dr Rajen Manicka and Chan Heng Fai were not involved in this decision making process given their interest in iGalen.
The DR and Chan could not be involved because of their interest in iGalen...HHHMMMM, Where is Jonathan Pager(oh hes gone, coincidence?)
23. Does HCT consider that its Code of Conduct provisions with respect to ‘Conflict of Interest’ have been adhered in relation to dealings between HCT and iGalen? In answering this question, please comment specifically on the actions of Rajen Manicka in circumstances where the iGalen Supply Agreement was signed by Rajen Manicka on behalf of iGalen and the iGalen Loan Agreement was signed on behalf of HCT by Rajen Manicka. Yes. At all times the Board was fully informed and aware of Dr Rajen Manicka’s position with regards to iGalen. For the iGalen loan, the decision was made by the Board and Dr Rajen Manicka was allowed to sign the loan agreement on behalf of HCT as none of HCT Board members were on the Board of iGalen Malaysia nor was Dr Rajen Manicka a shareholder in iGalen Malaysia at that time (ie in 2016). As for Supply agreement with HCT, Daniel O’Connor signed on behalf of HCT and Dr Rajen Manicka signed on behalf of iGalen . iGalen Malaysia was an independent entity with no common shareholders between this company and any entity associated with HCT’s directors when the Loan Agreement were signed.
O'conner signed on behalf of HCT and thenDR signed on behalf of iGalen and their was NO common interest....OMG who are they trying to kid..
The company are being purseud by the ASX and will not be able to fart in future if still being able to trade, they are basically being asked all these questions because ASX can see through the bullshit.....
Food is making a loss after all the yrs of research and the sanitizer is only being kept alive in the sh's mind with testing in HK and testing with TGA, which we all(most)have come to the conclusion that its all imho bullshit....
Desperate is an understatement on how their position with ASX is and where it is heading..
Dr i believe has been taking from mum and dads for too long, i wonder if the scrambling for shares the last few days is the ASX coming down hard on them coming out with a top20?
They couldnt get away with now seeing a t20 less than what it was with out a disclosure being Ann'd and it would explain $200k traded today without the gain it should of had...
These questions will not be the last imho as these answers are dicey at best.....
HCT Price at posting:
6.1¢ Sentiment: Hold Disclosure: Held
(20min delay)